BACKGROUND:
Asthma is the most common chronic disease in children, imposing a consistent burden on the healthcare system. In Ayurveda, many formulations are described for managing Shwasa (respiratory disease) and Kasa (cough). Duralabhadi yoga is one of them, which is classically mentioned in Yogaratnakar, Balarogachikitsha, for the treatment of Shwasa (respiratory disease) and Kasa (cough). The present study aimed to identify the phytoactive components of Duralabhadi yoga, as well as the extracts of Vasa and Kantakari, and to learn more about how these phytoactive components affect the human respiratory system, particularly in the cases of childhood asthma.
METHODS:
For each of the content of Duralabhadi yoga samples and Vasa and Kantakari samples, a high resolution—liquid chromatography mass spectrometry analysis was conducted, and the phytochemical components were identified. Following that, it was determined which constituents impacted asthma and the human respiratory system with the aid of earlier research on these well-known phytochemicals available in databases like PubMed and ChEMBL.
RESULTS:
In Duralabha sample, 15 compounds have various effects on the respiratory system. 11 compounds have pharmacological action on the respiratory system in the sample of Pippali. In the sample of Haritaki 12 compounds have pharmacological action on the respiratory system. Sixteen compounds each have various effects on the respiratory system in Draksha and Vasa sample. Nine compounds have pharmacological action on the respiratory system in the sample of Kantakari.
CONCLUSIONS:
The phytoactive compounds found in Vasa, Kantakari, and the various contents of Duralabhadi yoga formulation have the effects of being bronchodilator, anti-inflammatory, antitussive, and anti-allergic.